Seeking Alpha

Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six...

Abbott Labs (ABT -0.5%) reports prescriptions for its drug Niaspan fell 5% from the level six weeks ago when a study was released showing the medicine failed to prevent heart attacks. The firm told analysts on a conference call this morning the price of Niaspan was raised earlier this year, offsetting the decline in prescriptions.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)